Adobe: I’ll start with my old label
Adobe is planning to stop manufacturing and selling its new line of digital medical devices in Europe.
The company announced Tuesday that it will begin selling devices in the United States by the end of the year.
Adobe will no longer manufacture or sell digital medical products in Europe, according to a company statement.
“This decision is a direct response to the rapid growth of the global medical device market and the continued demand for digital medical technology,” Adobe CEO Kevin McNerney said in the statement.
Adobe says the company is now in talks with its European partners about the move.
The announcement comes less than a year after Adobe announced it was moving its headquarters from Austin, Texas, to San Francisco.
It said it will close the Austin plant in 2019.
Adobe’s European business will continue, however, as Adobe continues to focus on its other businesses in Europe and Asia.
Adobe is expected to announce additional details about the new business in the coming months.
In addition to moving its HQ, Adobe said it has decided to move its headquarters to Dublin, Ireland.
The new headquarters is expected have up to 3,500 employees, Adobe told the Financial Times.
Adobe also said it was adding a new business unit, Creative Care, which will focus on medical software and services for the medical community.
Adobe said in December that it was cutting $200 million in costs by eliminating manufacturing in the European Union.